Compelo Medical Devices - Latest industry news and analysis is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

Implant Sciences Appoints New CEO

Implant Sciences Corporation (Implant Sciences) has appointed Glenn D. Bolduc as president, chief executive officer (CEO) and to its board, effective January 1, 2009. Before this, Bolduc held the position of chief financial officer. Phillip C. Thomas resigned his positions as the company's president, chief executive officer and chairman, effective December 31, 2008 to pursue other personal interests.

Phillip C. Thomas stated, “Almost two years ago I joined Implant Sciences and was charged with the task of leading the Company through a major restructuring enabling the Company to be more competitive in the Security, Safety and Defense (SS&D) industry. During my tenure, we disposed of non-strategic assets; built an industry-focused team capable of meeting the challenges within the SS&D marketplace; made significant sales progress, especially in penetrating the international marketplace; and strengthened our overall financial position during difficult economic times. I believe the Company’s restructuring goals have been accomplished, as have my own personal goals. The time is right to hand the reins of the Company over to Glenn Bolduc, who I am certain, will continue executing on the Company’s strategic plan.”

Glenn D. Bolduc, president and chief executive officer of Implant Sciences, commented, “We are most appreciative of Phil Thomas’ leadership and his efforts to position the Company to be a pure-play in the SS&D industry. With the repositioning task behind us, we are keenly focused on executing our growth plan. We believe our organization has now been properly streamlined so as to be able to take advantage of growth opportunities while doing so in a cost-effective manner. While drawing upon my past experiences in leading companies facing challenges similar to those faced by Implant Sciences today, I look forward to working with our experienced and knowledgeable team in executing our strategic plan. We believe our talented staff and innovative technology form the foundation upon which Implant Sciences can grow into a market leader in the SS&D industry.”